Evidence map›Paper›PMID 28386631›Full record

ReviewApplied microbiology and biotechnology2017

Microbial rhamnolipid production: a critical re-evaluation of published data and suggested future publication criteria.

Victor U Irorere, Lakshmi Tripathi, Roger Marchant, Stephen McClean, Ibrahim M Banat

Open access · hybridAbstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Recombinant Production ofMicroorganisms · 2024
    Article
  6. DoE-based medium optimization for improved biosurfactant production withFrontiers in bioengineering and biotechnology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Achieving Commercial Applications for Microbial Biosurfactants.Advances in biochemical engineering/biotechnology · 2022
    Article
  12. Bacterial rhamnolipids and their 3-hydroxyalkanoate precursors activateProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Victor U IrorereSchool of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine, Co. Londonderry, BT52 1SA, UK.
Lakshmi TripathiSchool of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine, Co. Londonderry, BT52 1SA, UK.
Roger MarchantSchool of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine, Co. Londonderry, BT52 1SA, UK.
Stephen McCleanSchool of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine, Co. Londonderry, BT52 1SA, UK.
Ibrahim M BanatSchool of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine, Co. Londonderry, BT52 1SA, UK. im.banat@ulster.ac.uk.
University of Ulster · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High production cost and potential pathogenicity of Pseudomonas aeruginosa, commonly used for rhamnolipid synthesis, have led to extensive research for safer producing strains and cost-effective production methods. This has resulted in numerous research publications claiming new non-pathogenic producing strains and novel production techniques many of which are unfortunately without proper characterisation of product and/or producing strain/s. Genes responsible for rhamnolipid production have only been confirmed in P. aeruginosa, Burkholderia thailandensis and Burkholderia pseudomallei. Comparing yields in different publications is also generally unreliable especially when different methodologies were used for rhamnolipid quantification. After reviewing the literature in this area, we strongly feel that numerous research outputs have insufficient evidence to support claims of rhamnolipid-producing strains and/or yields. We therefore recommend that standards should be set for reporting new rhamnolipid-producing strains and production yields. These should include (1) molecular and bioinformatic tools to fully characterise new microbial isolates and confirm the presence of the rhamnolipid rhl genes for all bacterial strains, (2) using gravimetric methods to quantify crude yields and (3) use of a calibrated method (high-performance liquid chromatography or ultra-performance liquid chromatography) for absolute quantitative yield determination.

Indexed as

BacteriaBurkholderiaChromatography, High Pressure LiquidFermentationGlycolipidsPseudomonas aeruginosaPublishingSurface-Active AgentsGlycolipidsrhamnolipidSurface-Active AgentsBiosurfactant quantificationBiosurfactantsMicrobial identificationRhamnolipidRhamnolipid genes

Identifiers

PMID28386631
PMCPMC5403872
OpenAlexW2604915145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.